ARG40802

anti-GALE antibody

anti-GALE antibody for IHC-Formalin-fixed paraffin-embedded sections,Western blot and Human,Mouse,Rat

Overview

Product Description Rabbit Polyclonal antibody recognizes GALE
Tested Reactivity Hu, Ms, Rat
Tested Application IHC-P, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name GALE
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 129-348 of Human GALE (NP_001121093.1).
Conjugation Un-conjugated
Alternate Names UDP-GlcNAc 4-epimerase; SDR1E1; UDP-galactose 4-epimerase; Galactowaldenase; EC 5.1.3.2; EC 5.1.3.7; UDP-N-acetylglucosamine 4-epimerase; UDP-GalNAc 4-epimerase; UDP-N-acetylgalactosamine 4-epimerase; UDP-glucose 4-epimerase

Application Instructions

Application Suggestion
Tested Application Dilution
IHC-P1:50 - 1:200
WB1:500 - 1:2000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control HeLa
Observed Size 36 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 2582 Human GALE

GeneID: 74246 Mouse GALE

Swiss-port # Q14376 Human UDP-glucose 4-epimerase

Swiss-port # Q8R059 Mouse UDP-glucose 4-epimerase

Gene Symbol GALE
Gene Full Name UDP-galactose-4-epimerase
Background This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Function Catalyzes two distinct but analogous reactions: the reversible epimerization of UDP-glucose to UDP-galactose and the reversible epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The reaction with UDP-Gal plays a critical role in the Leloir pathway of galactose catabolism in which galactose is converted to the glycolytic intermediate glucose 6-phosphate. It contributes to the catabolism of dietary galactose and enables the endogenous biosynthesis of both UDP-Gal and UDP-GalNAc when exogenous sources are limited. Both UDP-sugar interconversions are important in the synthesis of glycoproteins and glycolipids. [UniProt]
Calculated MW 38 kDa

Images (1) Click the Picture to Zoom In

  • ARG40802 anti-GALE antibody WB image

    Western blot: 25 µg of HeLa cell lysate stained with ARG40802 anti-GALE antibody at 1:1000 dilution.